Literature DB >> 4208645

Exploitation of the oxygen enhancement ratio in clinical practice.

W Duncan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4208645     DOI: 10.1093/oxfordjournals.bmb.a070953

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  7 in total

1.  Editorial: Oxygen and radiotherapy.

Authors: 
Journal:  Br Med J       Date:  1974-10-19

2.  Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxia.

Authors:  C U Ludwig; Y M Peng; J N Beaudry; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Oxygenation of tumors by a hemoglobin solution.

Authors:  B A Teicher; G N Schwartz; E Alvarez Sotomayor; M F Robinson; N P Dupuis; K Menon
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 4.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.

Authors:  B A Teicher; T S Herman; J Tanaka; B Dezube; A Pardee; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 6.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

7.  Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials.

Authors:  Benjamin Schmidt; Hae-June Lee; Sandra Ryeom; Sam S Yoon
Journal:  Curr Angiogenes       Date:  2012-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.